稳定STEMI患者多血管再血管化的时间:系统性审查和网络元分析
Felix Voll1, Constantin Kuna1, Maria Scalamogna2
1Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
Revista espanola de cardiologia (English ed.)
|June 27, 2024
概括
多血管穿皮冠状动脉干预 (MV-PCI) 在ST段升高心肌梗塞 (STEMI) 索引住院期间,多血管冠状动脉疾病 (CAD) 减少死亡和再血管. 这种方法比罪祸首的PCI更安全,更有效.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 临床试验 临床试验
背景情况:
- 多血管冠状动脉疾病 (CAD) 的ST段升高心肌梗塞 (STEMI) 通常需要干预.
- 目前的指导方针建议在没有心脏性休克的STEMI患者中进行多血管穿皮冠状动脉干预 (MV-PCI).
- 在这种患者群体中,MV-PCI的最佳时间仍在研究中.
研究的目的:
- 为了确定MV-PCI在没有心脏性休克的STEMI和多血管CAD患者的最佳时间.
- 为了比较不同MV-PCI计时策略的有效性和安全性,与罪祸首船只的PCI相比.
主要方法:
- 一个网络元分析11个随机试验,涉及10,507名患者.
- 患者被分配到MV-PCI (同坐,指数住院期间分阶段,或随后住院期间分阶段) 或罪祸首血管单独PCI.
- 主要结局是全因死亡;次要结局包括心血管死亡,心肌梗塞和无计划的再血管化.
主要成果:
- 在指数住院期间进行的MV-PCI相比,与罪祸首只为船舶的PCI相比,所有原因的死亡率显著降低 (RR 0.73;P=.008).
- MV-PCI,无论时间如何,降低了心血管疾病死亡率.
- 在指数住院 (单次或分阶段) 中,MV-PCI显著减少了心肌梗塞和计划外再血管.
结论:
- 在指数住院期间 (单次或分阶段) 进行的MV-PCI是STEMI患者最安全和最有效的策略,患者有多血管CAD而没有心脏性休克.
- MV-PCI的时间没有显著影响全因死亡率.
- 这种方法通过减少主要的不良心脏事件来改善结果.
关键词:
冠状动脉疾病是一种冠状动脉疾病.患有冠状动脉病的人.心肌梗塞是心肌梗塞的一种疾病.冠状动脉干预是通过皮肤进行的.进行元分析分析.进行金属分析.多种类型的多种类型的.多艘船只的船只.心肌梗塞的心脏病发作通过皮肤进行冠状动脉干预.更多相关视频
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.0K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
相关概念视频
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...